Virax Biolabs Group Ltd (VRAX) Operating cash flow 2021–2025
Virax Biolabs Group Ltd (VRAX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.6MFY2025 · since FY2021: -$590,186 → -$4.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.6M | +26.9% |
| FY2024 | -$6.2M | -49.5% |
| FY2023 | -$4.2M | -416.6% |
| FY2022 | -$809,070 | -37.1% |
| FY2021 | -$590,186 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VRAX financial trends
VRAX RevenueVRAX Net incomeVRAX Net marginVRAX Gross profitVRAX Gross marginVRAX Operating incomeVRAX Operating marginVRAX Free cash flowVRAX Capital expendituresVRAX Return on equityVRAX Stock buybacksVRAX Dividends paidVRAX Total assetsVRAX Total liabilitiesVRAX Shareholders’ equityVRAX overview →